Your browser doesn't support javascript.
loading
Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cells.
Bier, Julia; Rao, Geetha; Payne, Kathryn; Brigden, Henry; French, Elise; Pelham, Simon J; Lau, Anthony; Lenthall, Helen; Edwards, Emily S J; Smart, Joanne M; Cole, Theresa S; Choo, Sharon; Joshi, Avni Y; Abraham, Roshini S; O'Sullivan, Michael; Boztug, Kaan; Meyts, Isabelle; Gray, Paul E; Berglund, Lucinda J; Hsu, Peter; Wong, Melanie; Holland, Steven M; Notarangelo, Luigi D; Uzel, Gulbu; Ma, Cindy S; Brink, Robert; Tangye, Stuart G; Deenick, Elissa K.
Afiliación
  • Bier J; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
  • Rao G; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia.
  • Payne K; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia.
  • Brigden H; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; University of Bath, Bath, United Kingdom.
  • French E; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; University of Bath, Bath, United Kingdom.
  • Pelham SJ; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
  • Lau A; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
  • Lenthall H; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia.
  • Edwards ESJ; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
  • Smart JM; Department of Allergy and Immunology, Royal Children's Hospital Melbourne, Melbourne, Australia.
  • Cole TS; Department of Allergy and Immunology, Royal Children's Hospital Melbourne, Melbourne, Australia.
  • Choo S; Department of Allergy and Immunology, Royal Children's Hospital Melbourne, Melbourne, Australia.
  • Joshi AY; Division of Allergy and Immunology, Mayo Clinic Children's Center, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn.
  • Abraham RS; Division of Allergy and Immunology, Mayo Clinic Children's Center, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • O'Sullivan M; Department of Immunology and Allergy, Princess Margaret Hospital, Subiaco, Australia.
  • Boztug K; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; St Anna Children's Hospital and Children's Cancer Research Institute, Department of Pediatrics and Adolescent Medicine, Med
  • Meyts I; Department of Immunology and Microbiology, Childhood Immunology, Department of Pediatrics, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
  • Gray PE; School of Women's and Children's Health, University of New South Wales, Sydney, Australia; Clinical Immunogenomics Research Consortia Australia, Sydney, Australia.
  • Berglund LJ; Clinical Immunogenomics Research Consortia Australia, Sydney, Australia; Immunopathology Department, Westmead Hospital, Westmead, Australia; Faculty of Medicine, University of Sydney, Sydney, Australia.
  • Hsu P; Clinical Immunogenomics Research Consortia Australia, Sydney, Australia; Faculty of Medicine, University of Sydney, Sydney, Australia; Children's Hospital at Westmead, Westmead, Australia.
  • Wong M; Clinical Immunogenomics Research Consortia Australia, Sydney, Australia; Faculty of Medicine, University of Sydney, Sydney, Australia; Children's Hospital at Westmead, Westmead, Australia.
  • Holland SM; Laboratory of Clinical Immunology and Microbiology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Uzel G; Laboratory of Clinical Immunology and Microbiology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Ma CS; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia; Clinical Immunogenomics Research Consortia Australia, Sydney, Australia.
  • Brink R; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia; Clinical Immunogenomics Research Consortia Australia, Sydney, Australia.
  • Tangye SG; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia; Clinical Immunogenomics Research Consortia Australia, Sydney, Australia. Electronic address: s.tangye@garvan.org.au.
  • Deenick EK; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia; Clinical Immunogenomics Research Consortia Australia, Sydney, Australia. Electronic address: e.deenick@garvan.org.au.
J Allergy Clin Immunol ; 144(1): 236-253, 2019 07.
Article en En | MEDLINE | ID: mdl-30738173

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Diferenciación Celular / Fosfatidilinositol 3-Quinasas Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2019 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Diferenciación Celular / Fosfatidilinositol 3-Quinasas Límite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2019 Tipo del documento: Article País de afiliación: Australia